Dynamic Contrast-Enhanced MRI of Cervical Tumors During Chemo-Radiation Correlated to Tumor Regression

Uulke A. van der Heide¹, Catalina Arteaga de Castro¹, Greetje Groenendaal¹, Cornelis A.T. van den Berg¹, Ina M. Jurgenliemk-Schulz¹, Judith M. Roesink¹

Dynamic contrast-enhanced MRI was used to monitor cervical tumors prior to and in the first four weeks of chemoradiation. An increase in Ktrans was observed in the first four weeks. Also Ktrans in the poorest perfused part of the tumor seems indicative for the rate of tumor regression.